India’s “silent epidemic”: 2 diagnostic stocks to watch as lifestyle diseases surge

India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are revolutionising India’s medical future.

Nov 3, 2025 - 03:00
 0  16
India’s “silent epidemic”: 2 diagnostic stocks to watch as lifestyle diseases surge
India’s ₹26B diagnostic boom is reshaping healthcare. Discover how Dr Lal PathLabs and Thyrocare Technologies are revolutionising India’s medical future.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow